About Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome
Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome is a rare disease catalogued by Orphanet (ORPHA:1154). It is associated with the PIEZO2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome trials.
Search ClinicalTrials.gov for "Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome" or filter by Orphanet code ORPHA:1154 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome. Updated daily.